| Primary |
| Asthma |
45.3% |
| Chronic Obstructive Pulmonary Disease |
12.4% |
| Drug Use For Unknown Indication |
10.6% |
| Product Used For Unknown Indication |
8.9% |
| Dyspnoea |
3.0% |
| Bronchitis |
2.5% |
| Wheezing |
2.2% |
| Emphysema |
2.0% |
| Pneumonia |
2.0% |
| Migraine |
1.5% |
| Bronchospasm |
1.2% |
| Convulsion |
1.2% |
| Cough |
1.2% |
| Atrial Fibrillation |
1.0% |
| Bronchitis Chronic |
1.0% |
| Pseudomonas Bronchitis |
1.0% |
| Blood Pressure Increased |
0.7% |
| Bronchiectasis |
0.7% |
| Condition Aggravated |
0.7% |
| Supplementation Therapy |
0.7% |
|
| Drug Ineffective |
11.3% |
| Dyspnoea |
10.6% |
| Wheezing |
10.6% |
| Product Quality Issue |
7.3% |
| Lactic Acidosis |
6.0% |
| Tremor |
6.0% |
| Metabolic Acidosis |
5.3% |
| Pharmaceutical Product Complaint |
4.6% |
| Pneumonia |
4.6% |
| Poor Quality Drug Administered |
4.0% |
| Asthma |
3.3% |
| Medication Error |
3.3% |
| Tachycardia |
3.3% |
| Tachypnoea |
3.3% |
| Therapeutic Response Decreased |
3.3% |
| Throat Irritation |
3.3% |
| Drug Effect Decreased |
2.6% |
| Overdose |
2.6% |
| Respiratory Distress |
2.6% |
| Cerebrovascular Accident |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.4% |
| Asthma |
29.4% |
| Chronic Obstructive Pulmonary Disease |
9.9% |
| Dyspnoea |
3.7% |
| Drug Use For Unknown Indication |
2.9% |
| Atrial Fibrillation |
2.8% |
| Depression |
2.8% |
| Bronchitis |
2.2% |
| Diabetes Mellitus |
2.0% |
| Emphysema |
2.0% |
| Anxiety |
1.6% |
| Cough |
1.5% |
| Migraine |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Bronchitis Chronic |
1.1% |
| Oedema |
1.1% |
| Arthralgia |
0.9% |
| Cardiac Disorder |
0.9% |
| Oedema Peripheral |
0.9% |
| Hepatic Enzyme Increased |
0.8% |
|
| Hallucination |
16.5% |
| Drug Ineffective |
12.8% |
| Dyspnoea |
7.3% |
| Lactic Acidosis |
6.4% |
| Fall |
5.5% |
| Feeling Abnormal |
5.5% |
| Asthma |
4.6% |
| Heart Rate Increased |
3.7% |
| Obesity |
3.7% |
| Oedema Peripheral |
3.7% |
| Pain In Extremity |
3.7% |
| Umbilical Hernia Repair |
3.7% |
| Wheezing |
3.7% |
| Drug Hypersensitivity |
2.8% |
| Liposarcoma |
2.8% |
| Paraesthesia |
2.8% |
| Pneumonia |
2.8% |
| Pyrexia |
2.8% |
| Tachycardia |
2.8% |
| Vomiting |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.9% |
| Drug Use For Unknown Indication |
13.0% |
| Asthma |
12.3% |
| Chronic Obstructive Pulmonary Disease |
9.0% |
| Dyspnoea |
6.3% |
| Hypertension |
3.8% |
| Pain |
3.7% |
| Emphysema |
2.7% |
| Diabetes Mellitus |
1.7% |
| Depression |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Osteoporosis |
1.5% |
| Anxiety |
1.4% |
| Hypersensitivity |
1.3% |
| Rheumatoid Arthritis |
1.2% |
| Wheezing |
1.2% |
| Cough |
1.0% |
| Crohn's Disease |
1.0% |
| Bronchitis Chronic |
0.9% |
| Blood Cholesterol Increased |
0.9% |
|
| Drug Ineffective |
10.4% |
| Vomiting |
10.3% |
| Dyspnoea |
6.6% |
| Pneumonia |
6.6% |
| Weight Decreased |
6.5% |
| Wheezing |
5.9% |
| Hypersensitivity |
5.0% |
| Urticaria |
4.8% |
| Asthma |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Death |
4.5% |
| Nausea |
3.8% |
| Pyrexia |
3.8% |
| Pulmonary Embolism |
3.5% |
| Urinary Tract Infection |
3.5% |
| Pain |
3.4% |
| Suicidal Ideation |
3.1% |
| Tremor |
3.1% |
| Weight Increased |
3.1% |
| Visual Impairment |
2.8% |
|
| Interacting |
| Dyspnoea |
47.4% |
| Arthralgia |
10.5% |
| Abdominal Discomfort |
5.3% |
| Ex-tobacco User |
5.3% |
| Gastric Disorder |
5.3% |
| Nerve Degeneration |
5.3% |
| Nervous System Disorder |
5.3% |
| Smoking Cessation Therapy |
5.3% |
| Thyroid Cancer |
5.3% |
| Thyroidectomy |
5.3% |
|
| Abasia |
33.3% |
| Cerebrovascular Accident |
33.3% |
| Vision Blurred |
33.3% |
|
